Ethical Compliance
IPCA LABORATORIES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
1.5%
Debt
12.5%
Liquidity
2.7%
Revenue
Debt
Liquidity
1.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharma Products | ₹7,464.21 |
| Sale of Services | ₹158.20 |
| Other Operating Revenue | ₹82.63 |
| Other Income | ₹7.13 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹117.64 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹117.64 |
| Total: | ₹117.64 |
| Total Revenue: | ₹7,829.81 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹117.64
₹7,829.81
= 1.5%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
